Benjamin Catanese

Conference Circulation · November 12, 2024 Background: Despite the substantial cardiovascular (CV) risk experienced by people with end-stage kidney disease (ESKD), few medications improve CV outcomes in this population. Glucagon-like peptide-1 ... Full text Cite

Effects of Interleukin-6 Inhibition with Clazakizumab on Anemia and Iron Parameters in Patients with Kidney Failure

Conference Journal of the American Society of Nephrology · October 2024 Full text Cite

FROM SOIL TO THE PERITONEUM: FUNGAL PERITONITIS WITH PAECILOMYCES VARIOTII

Conference AMERICAN JOURNAL OF KIDNEY DISEASES · April 2023 Link to item Cite

Chicken or the Egg Causality Dilemma: Primary ANCA Vasculitis Complicated by Infective Endocarditis (IE) vs. IE Leading to ANCA Vasculitis

Conference JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY · October 2021 Link to item Cite

Obesity and Survival in Women with Invasive Breast Cancer Receiving Neoadjuvant Chemotherapy: Role of Tumor Subtype and Race

Conference International Journal of Radiation Oncology*Biology*Physics · October 2017 Full text Cite

Environmental life cycle information management and acquisition - First experiences and results from field trials

Conference Electronics Goes Green 2004 (Plus): Driving Forces for Future Electronics, Proceedings · 2004 Link to item Cite

THE PHARMACOKINETICS OF ORAL LONIDAMINE IN BREAST AND LUNG-CANCER PATIENTS

Conference BRITISH JOURNAL OF CANCER · September 1990 Link to item Cite